Logo

High-Throughput Genomics Awarded NCI Grant for Toxicity Testing, Array Development

Mar 16, 2004

NEW YORK, March 16 (GenomeWeb News) - High-Throughput Genomics has been awarded a two-year, $500,000 grant from the National Cancer Institute to identify and validate sets of genes for toxicity studies and develop a new array product, the company said today.

HTG said it plans to make "two-pronged" use of the funds, awarded by NCI's Division of Cancer Treatment & Diagnosis.

The company first plans to identify and validate a set of genes that can be used to predict the toxicity of compounds before testing in animals or humans. HTG said it will also use the funds to develop and validate a new medium-density array -- measuring 75 to 300 genes per well - to measure DNA, RNA, or protein molecules.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.